Keyword Suggestion
Domain Informations
Lignamed.com lookup results from whois.cloudflare.com server:
- Domain created: 2013-04-19T01:22:27Z
- Domain updated: 2024-03-20T20:03:40Z
- Domain expires: 2025-04-19T01:22:27Z 0 Years, 356 Days left
- Website age: 11 Years, 8 Days
- Registrar Domain ID: 1794892909_DOMAIN_COM-VRSN
- Registrar Url: http://www.cloudflare.com
- Registrar WHOIS Server: whois.cloudflare.com
- Registrar Abuse Contact Email:
- Registrar Abuse Contact Phone: Not Available
- Name server:
- ANGELA.NS.CLOUDFLARE.COM
- SID.NS.CLOUDFLARE.COM
Network
- inetnum : 172.64.0.0 - 172.71.255.255
- name : CLOUDFLARENET
- handle : NET-172-64-0-0-1
- status : Direct Allocation
- created : 2010-07-09
- changed : 2021-07-01
- desc : All Cloudflare abuse reporting can be done via https://www.cloudflare.com/abuse
Owner
- organization : Cloudflare, Inc.
- handle : CLOUD14
- address : Array,San Francisco,CA,94107,US
Abuse
- handle : ABUSE2916-ARIN
- name : Abuse
- phone : +1-650-319-8930
- email : [email protected]
Technical support
- handle : ADMIN2521-ARIN
- name : Admin
- phone : +1-650-319-8930
- email : [email protected]
Domain Provider | Number Of Domains |
---|---|
godaddy.com | 286730 |
namecheap.com | 101387 |
networksolutions.com | 69118 |
tucows.com | 52617 |
publicdomainregistry.com | 39120 |
whois.godaddy.com | 32793 |
enomdomains.com | 23825 |
namesilo.com | 21429 |
domains.google.com | 21384 |
cloudflare.com | 20573 |
gmo.jp | 18110 |
name.com | 17601 |
fastdomain.com | 14708 |
register.com | 13495 |
net.cn | 12481 |
ionos.com | 12416 |
ovh.com | 12416 |
gandi.net | 12305 |
registrar.amazon.com | 12111 |
Host Informations
- IP address: 172.67.152.168
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Site Inspections
Port Scanner (IP: 172.67.152.168)
Spam Check (IP: 172.67.152.168)
Recent Searched Sites
› Masterbrowsbr.com (1 mins ago) / US
› Lignamed.com (0 seconds ago) / US
› Toryu.se (9 seconds ago) / US
› Ecomdudes.com (29 seconds ago) / US
› Rabahtechtechno.com (17 seconds ago) / US
› Actamaps.be (54 seconds ago) / BE
› Js11.cc (11 seconds ago) / US
› Tasapisi.ee (2 mins ago) / EE
› Recaro-automotive.com (26 seconds ago) / US
› Domashnakunyasdani.com (39 seconds ago) / BG
› Fortis-combi.com (8 seconds ago) / DE
› Carrymagazine.com (1 mins ago) / DE
› Consuunt.com (26 seconds ago) / ES
› Jccayer.com (12 seconds ago) / US
› Drageesanahita.com (5 seconds ago) / FR
› Tokyotower.co.jp (36 seconds ago) / JP
› Rsrgroup.com (14 seconds ago) / US
› Coslinic.com (7 seconds ago) / CN
› Allysondbrown.com (1 mins ago) / FR
› Globalprice.info (21 seconds ago) / RU
Websites Listing
We found Websites Listing below when search with lignamed.com on Search Engine
Product - LignaMed LLC
Unmet Medical Needs Th2-low asthma There is no effective treatment to mitigate Th2-low asthma, for which there are 170,000 patients in the U.S. Lung Transplants There is a need to rehabilitate and improve lung function and preserve donor lungs ex-vivo to increase the supply of viable lungs and improve outcomes for transplantation for individuals with […]
Lignamed.comWho We Are - LignaMed LLC
Christofidou-Solomidou is an inventor, holder of several US patents and an entrepreneur, founder of LignaMed, LLC and co-founder of JT-MeSh Diagnostics, LLC in collaboration with Upenn. Dr. Christofidou-Solomidou received her bachelor’s degree from the State University of New York (SUNY) at Stony Brook and her doctoral degree from the University of Bonn in Germany. She …
Lignamed.comLignamed, Llc | Company Email | Telephone | Contact ...
Contact details (email, telephone numbers etc.) for Lignamed, Llc
Pharmacompass.comDevelopment Plan - LignaMed LLC
LignaMed expects to complete preclinical studies for LGM2605 as device in lung transplant in 2021. 2022. LignaMed plans to submit device package for lung transplant in 2022. Clinical Studies. Initiation of clinical studies for asthma is planned for 2022. Completion of clinical studies for device is planned for 2022 . Submit IND Application to FDA. An IND submission for asthma …
Lignamed.comNews - LignaMed LLC
2019-12-19 · December 19, 2019 LignaMed Announces Publication of Data on Lead Candidate LGM2605 Demonstrating Protective Effect on Airway Hyperreactivity in Asthma
Lignamed.comLignamed, LLC | SBIR.gov
Lignamed, LLC. Company Information. Address. 3675 Market St Ste 200. Philadelphia, PA 19104-2897. United States. Information. DUNS: 078829605 # of Employees: 3. Ownership Information. HUBZone Owned: Yes. Socially and Economically Disadvantaged: No. Woman Owned: No. Award Charts. Award Listing. Download Record 1 TO 7 . Optimization of …
Sbir.govLignamed, LLC
Lignamed, LLC Trade Name ("Doing Business As ..."): DUNS Number: 078829605 Parent DUNS Number: Address, line 1: 3711 Market St Ste 866 Address, line 2: City: Philadelphia State: PA Zip: 19104-5504 Phone Number: 215-206-2754 Fax Number: E-mail Address: [email protected] WWW Page: www.lignamed.com. E-Commerce Website: Contact Person: James B Harris …
Cage.reportOptimization of LGM2605 for use as a device in lung ... - SBIR
Email: [email protected]. Business Contact. Name: JIM HARRIS Phone: (215) 206-2754 Email: [email protected]. Research Institution. N/A . Abstract. LignaMed, LLC is developing a novel small molecule device, LGM2605, that will be utilized and administered via FDA approved ex vivo lung perfusion (EVLP), to improve lung function parameters of ex vivo …
Sbir.govLignamed, Llc
LIGNAMED, LLC CAGE CODE 6WNG9. Llc Lignamed has a registered in the System for Award Management for doing business with and bidding for contracts by the United States government. Cage Code 6WNG9 was listed as their unique company identifier. The company registered with SAM on 2013-05-15 and the registration with the below details.
Cage.reportIND enabling development of LGM2605 as adjuvant ... - SBIR
Email: [email protected]. Research Institution. Name: UNIVERSITY OF CALIFORNIA AT DAVIS Address: 1850 Research Park Drive, Suite 300. DAVIS, CA 95618-6153. United States . Type: Nonprofit college or university. Abstract. Project summary IND enabling development of LGM2605 as adjuvant treatment for asthma Glucocorticoid resistance is a major treatment …
Sbir.govGraft-protective properties of LGM2605 in Lung ... - SBIR
Email: [email protected]. Business Contact. Name: JIM HARRIS Phone: (215) 206-2754 Email: [email protected]. Research Institution. Name: UNIVERSITY OF PENNSYLVANIA Address: 3451 WALNUT STREET. PHILADELPHIA, PA 19104-6205. United States. Type: Nonprofit college or university. Abstract . LignaMedLLC is developing LGMa …
Sbir.govDavid Leach - Chief Executive Officer - LignaMed ...
2022-01-23 · Description. LignaMed, LLC, is biotechnology company developing breakthrough treatments for asthma, organ transplant viability and fibrosis. Lead candidate LGM2605 is a novel small molecule synthetic lignan with anti-inflammatory and antioxidant properties.
Zoominfo.comLignaMed Information | LignaMed Profile
LignaMed, LLC, is biotechnology company developing breakthrough treatments for asthma, organ transplant viability and fibrosis. Lead candidate LGM2605 is a novel small molecule synthetic lignan with anti-inflammatory and antioxidant properties. LignaMed holds exclusive licenses to the patents for LGM2605 from The Trustees of the University of Pennsylvania and …
Rocketreach.coLignaMed Company Profile | Management and Employees List
LignaMed, LLC, is biotechnology company developing breakthrough treatments for asthma, organ transplant viability and fibrosis. Lead candidate LGM2605 is a novel small molecule synthetic lignan with anti-inflammatory and antioxidant properties. LignaMed holds exclusive licenses to the patents for LGM2605 from The Trustees of the University of Pennsylvania and …
Datanyze.comLGM2605 as a Mitigator of Space Radiation-Induced Vascular ...
Name: James Harris Phone: (215) 206-2754 Email: [email protected]
Sbir.govLignamed, LLC | Philadelphia | Pennsylvania | US Database ...
Get to know about Lignamed, LLC - , Company details, Directors name, Contact details, Email Ids, and more.
Bestdataprovider.comSBIR-17-1-H12.01-8754 | Abstract - LGM2605 as a mitigator ...
LignaMed, LLC 3711 Market Street Philadelphia, PA 19104 - 5501 (215) 206-2754 PRINCIPAL INVESTIGATOR/PROJECT MANAGER (Name, E-mail, Mail Address, City/State/Zip, Phone) Dr Thais Sielecki [email protected] 3711 Market Street Philadelphia, PA 19104 - 5501 (610) 299-7482. CORPORATE/BUSINESS OFFICIAL (Name, E-mail, Mail Address, …
Sbir.nasa.govLignamed, LLC - VentureRadar
" LignaMed, LLC, is biotechnology company developing breakthrough treatments for asthma, organ transplant viability and fibrosis. Lead candidate LGM2605 is a novel small molecule synthetic lignan with anti-inflammatory and antioxidant properties. LignaMed holds exclusive licenses to the patents for LGM2605 from The Trustees of the University of Pennsylvania and …
Ventureradar.comLignamed, LLC Company Profile | Philadelphia, PA ...
Find company research, competitor information, contact details & financial data for Lignamed, LLC of Philadelphia, PA. Get the latest business insights from Dun & Bradstreet.
Dnb.comSBIR-17-2-H12.01-8754 | Abstract - LGM2605 as a Mitigator ...
LignaMed, LLC 3711 Market Street Philadelphia, PA 19104 - 5501 (215) 206-2754 PRINCIPAL INVESTIGATOR/PROJECT MANAGER (Name, E-mail, Mail Address, City/State/Zip, Phone) Dr. Thais M Sielecki-Dzurdz [email protected] 3711 Market Stree, Suite 866 Philadelphia, PA 19104 - 5501 (610) 299-7482 . CORPORATE/BUSINESS OFFICIAL (Name, …
Sbir.nasa.gov
Domains Expiration Date Updated
Site | Provider | Expiration Date |
---|---|---|
valleychevy1.com | godaddy.com | 1 Year, 223 Days |
love-boots.com | gmo.jp | -1 Years, -188 Days |
maspares.com | dinahosting.com | -1 Years, -299 Days |
detmir.com | nic.ru | -2 Years, -25 Days |
casinoforum.io | godaddy.com | -1 Years, -231 Days |
emberfund.io | godaddy.com | -2 Years, -13 Days |
cloud--shoes.com | zzy.cn | -1 Years, -299 Days |
pankori.net | netowl.jp | -1 Years, -91 Days |
yarnbark.com | domains.google.com | 280 Days |
risingotaku.com | namecheap.com | -1 Years, -69 Days |